NM-2201
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
|
|
| Clinical data | |
| Legal status |
|
| Identifiers | |
| CAS Number | 837122-21-7 |
| PubChem | CID 91864534 |
| ChemSpider | 30922478 |
| Chemical data | |
| Formula | C24H22FNO2 |
| Molar mass | 375.4 g/mol |
|
|
|
NM-2201 (also known as CBL-2201) is an indole-based synthetic cannabinoid that presumably has similar properties to the closely related 5F-PB-22 and NNE1, which are both full agonists and unselectively bind to CB1 and CB2 receptors with low nanomolar affinity.[1][2][3][4]
Legal status[edit]
NM-2201 is banned in Sweden[5] and Germany (Anlage II).
See also[edit]
References[edit]
- ^ A.A. Kondrasenko, E.V. Goncharov, K.P. Dugaev, A.I. Rubaylo (December 2015). "CBL-2201. Report on a new designer drug: Napht-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate". Forensic Science International 257: 209–213. doi:10.1016/j.forsciint.2015.08.023. PMID 26386336.
- ^ "NM-2201". Cayman Chemical. Retrieved 9 July 2015.
- ^ Akira Namera, Maho Kawamura, Akihiro Nakamoto, Takeshi Saito, Masataka Nagao (March 2015). "Comprehensive review of the detection methods for synthetic cannabinoids and cathinones". Forensic Toxicology 33: 175–194. doi:10.1007/s11419-015-0270-0.
- ^ V. Shevyrin, V. Melkozerov, A. Nevero, O. Eltsov, A. Baranovsky, Yu. Shafran (September 2014). "Synthetic cannabinoids as designer drugs: New representatives of indol-3-carboxylates series and indazole-3-carboxylates as novel group of cannabinoids. Identification and analytical data". Forensic Science International 244: 263–275. doi:10.1016/j.forsciint.2014.09.013.
- ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. Retrieved 9 July 2015.
|
 |
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
